Coya Therapeutics, Inc. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1289198,
    "name": "Coya Therapeutics, Inc.",
    "stock_name": "Coya Therapeutics, Inc.",
    "full_name": "Coya Therapeutics, Inc.",
    "name_url": "stocks-analysis/coya-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "6.00",
    "chg": 0.02,
    "chgp": "0.33%",
    "dir": 1,
    "prev_price": "5.98",
    "mcapval": "106.43",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Miscellaneous",
    "ind_code": 3205,
    "indexname": "S&P 500",
    "isin": "US22407B1089",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "195.93 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/coya-therapeutics-inc-1289198-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Coya Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-coya-therapeutics-inc-technically-bullish-or-bearish-3548159",
        "imagepath": "",
        "date": "2025-09-20 20:10:58",
        "description": "As of 28 August 2025, the technical trend for Coya Therapeutics, Inc. has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bearish, indicating mixed signals across time frames. The daily moving averages are mildly bullish, supporting the overall positive shift. However, the weekly KST and OBV are bearish, and the Bollinger Bands show a sideways trend on the weekly and bearish on the monthly. Dow Theory presents a mildly bearish stance weekly but mildly bullish monthly.\n\nIn terms of performance, Coya has underperformed the S&P 500 across all observed periods, with a year-to-date return of 0.17% compared to the S&P 500's 12.22%, and a one-year return of -5.28% against 17.14%. Overall, the current technical stance is mildly bullish, but caution is warranted due to mixed indicators and underperformance relative to the benchmark...."
      },
      {
        "title": "Is Coya Therapeutics, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-coya-therapeutics-inc-overvalued-or-undervalued-3544295",
        "imagepath": "",
        "date": "2025-09-20 18:42:39",
        "description": "As of 12 August 2025, the valuation grade for Coya Therapeutics, Inc. moved from risky to does not qualify, indicating a significant deterioration in its financial standing. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 2.94 and an EV to Sales ratio of 17.02, which suggest a high valuation relative to its financial performance. Additionally, the negative ROE of -51.35% further underscores the company's struggles.\n\nIn comparison to its peers, Coya Therapeutics, Inc. has a notably worse EV to EBITDA ratio of -3.23, while Gaia, Inc. has a much higher ratio of 10.4728, indicating a more favorable valuation in that regard. Similarly, Research Solutions, Inc. shows a significantly negative EV to EBITDA of 30.0380, reinforcing the challenges faced by Coya. Over the past year, Coya's stock has underperformed relative to the S&P 500, returning -5.28% compa..."
      }
    ],
    "total": 6,
    "sid": "1289198",
    "stock_news_url": "https://www.marketsmojo.com/news/coya-therapeutics-inc-1289198"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Coya Therapeutics, Inc. technically bullish or bearish?

2025-09-20 20:10:58

As of 28 August 2025, the technical trend for Coya Therapeutics, Inc. has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bearish, indicating mixed signals across time frames. The daily moving averages are mildly bullish, supporting the overall positive shift. However, the weekly KST and OBV are bearish, and the Bollinger Bands show a sideways trend on the weekly and bearish on the monthly. Dow Theory presents a mildly bearish stance weekly but mildly bullish monthly. In terms of performance, Coya has underperformed the S&P 500 across all observed periods, with a year-to-date return of 0.17% compared to the S&P 500's 12.22%, and a one-year return of -5.28% against 17.14%. Overall, the current technical stance is mildly bullish, but caution is warranted due to mixed indicators and underperformance relative to the benchmark....

Is Coya Therapeutics, Inc. overvalued or undervalued?

2025-09-20 18:42:39

As of 12 August 2025, the valuation grade for Coya Therapeutics, Inc. moved from risky to does not qualify, indicating a significant deterioration in its financial standing. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 2.94 and an EV to Sales ratio of 17.02, which suggest a high valuation relative to its financial performance. Additionally, the negative ROE of -51.35% further underscores the company's struggles. In comparison to its peers, Coya Therapeutics, Inc. has a notably worse EV to EBITDA ratio of -3.23, while Gaia, Inc. has a much higher ratio of 10.4728, indicating a more favorable valuation in that regard. Similarly, Research Solutions, Inc. shows a significantly negative EV to EBITDA of 30.0380, reinforcing the challenges faced by Coya. Over the past year, Coya's stock has underperformed relative to the S&P 500, returning -5.28% compa...

View All News